Acanthosis nigricans and diabetes risk factors: Prevalence in young persons seen in southwestern US primary care practices

Annals of Family Medicine

Volumn 5, Issue 3, 2007, Pages 202-208

  Kong, Alberta S ^a   Williams, Robert L ^a   Smith, Melissa ^a   Sussman, Andrew L ^a   Skipper, Betty ^a   Hsi, Andrew C ^a   Rhyne, Robert L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Acanthosis nigricans; Diabetes mellitus; Practice based research network; Primary care; Risk factors; Risk reduction; Screening

Indexed keywords

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; SCHOOL CHILD; UNITED STATES;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; OBESITY; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SOUTHWESTERN UNITED STATES;

EID: 34250019902     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.678     Document Type: Article

References (27)

1. American Diabetes Association. Diabetes statistics. 2006. Available at: http://www.diabetes.org/diabetes-statistics.jsp. Accessed: 28 June 2006.
2. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(Suppl 1):S11-S14.
3. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States. 2003. Available at: http://www.cdc.gov/diabetes/pubs/factsheet.htm. Accessed: 28 June 2006.
4. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care. 2002;25(4):742-749.
5. Crabtree BF, Miller WL, Tallia AF, et al. Delivery of clinical preventive services in family medicine offices. Ann Fam Med. 2005;3(5):430-435.
6. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635-641.
7. Drobac S, Brickman W, Smith T, Binns HJ. Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic. Pediatrics. 2004;114(1):141-148.
8. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol. 1992;128(7):941-944.
9. Kobaissi HA, Weigensberg MJ, Ball GD, et al. Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes. Diabetes Care. 2004;27(6):1412-1416.
10. Litonjua P, Pinero-Pilona A, Aviles-Santa L, Raskin P. Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract. 2004;10(2):101-106.
11. Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health. 2001;28(5):372-376.
12. Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009-1014.
13. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87(3):269-272.
14. Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health. 1994;84(11):1839-1842.
15. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999;22(10):1655-1659.
16. Stuart CA, Gilkison CR, Smith MM, et al. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila). 1998;37(2):73-79.
17. Burke JP, Duggirala R, Hale DE, Blangero J, Stern MP. Genetic basis of acanthosis nigricans in Mexican Americans and its association with phenotypes related to type 2 diabetes. Hum Genet. 2000;106(5):467-472.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):S43-S48.
19. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
21. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199-200.
22. Copeland K, Pankratz K, Cathey V, et al. Acanthosis nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children. J Okla State Med Assoc. 2006;99(1):19-24.
23. Yamazaki H, Ito S, Yoshida H. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children. Pediatr Int. 2003;45(6):701-705.
24. Hardin DS. Screening for type 2 diabetes in children with acanthosis nigricans. Diabetes Educ. 2006;32(4):547-552.
25. Dorsey KB, Wells C, Krumholz HM, Concato JC. Diagnosis, evaluation, and treatment of childhood obesity in pediatric practice. Arch Pediatr Adolesc Med. 2005;159(7):632-638.
26. Cook S, Weitzman M, Auinger P, Barlow SE. Screening and counseling associated with obesity diagnosis in a national survey of ambulatory pediatric visits. Pediatrics. 2005;116(1):112-116.
27. Sussman AL, Williams RL, Leverence R, Gloyd PW Jr, Crabtree BF. The art and complexity of primary care clinicians' preventive counseling decisions: obesity as a case study. Ann Fam Med. 2006;4(4):327-333.